Anticoagulation Management Service

The Hallmark Health System (HHS)  Anticoagulation Management Service (AMS) offers treatment to patients who are on blood thinning medications like warfarin, (Coumadin®), enoxaparin (Lovenox®), fondaparinux (Arixtra®), dabigatran (Pradaxa®), and rivaroxaban (Xarelto®), which are used to prevent blood clots from forming or becoming larger. The AMS is overseen by a medical director and anticoagulation pharmacists who closely monitor patients’ anticoagulation therapy. Close monitoring and appropriate follow-up allows for prompt intervention if dosage adjustments are needed, leading to better patient outcomes. Patients also receive counseling and education through the service.

Studies have shown that patients enrolled in a centralized anticoagulation management service have better INR control, decreased adverse events and better clinical outcomes.Typical patients include those with cardiac conditions, clotting disorders, post-orthopedic surgery and/or patients that recently suffered a stroke.

“Anticoagulation management using a centralized service really has become the standard of care in the field of anticoagulation by providing patients easy accessibility to a specialized clinician and a focused and individualized approach to anticoagulation management” says Antonia DeQuevedo, PharmD, CACP, AMS coordinator.

For more information about the service or the referral process, please contact us at (781) 224-5822.